ArticleDiscover oncology2023

Identification of galactosamine-(N-acetyl)-6-sulfatase (GALNS) as a novel therapeutic target in progression of nasopharyngeal carcinoma.

Jin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.